Physician profile
Mark Soliman
NPI 1902072663
$871,535.11
in general payments reported to CMS, 2019-2025
20 companies · $150K in 2025
The $150K reported for 2025 was more than what 99% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199K · 2020: $64K · 2021: $108K · 2022: $125K · 2023: $136K · 2024: $89K · 2025: $150K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $191K · Education: $95K · Travel and Lodging: $57K · Food and Beverage: $13K · Grant: $10K · Consulting Fee: $7,800 · Honoraria: $1,575 · Gift: $83.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $190,637.50 |
| Education | $95,200.00 |
| Travel and Lodging | $57,469.32 |
| Food and Beverage | $13,237.25 |
| Grant | $10,000.00 |
| Consulting Fee | $7,800.00 |
| Honoraria | $1,575.00 |
| Gift | $83.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $804,066.55 | 2019-2025 | Da Vinci Sp, Da Vinci Surgical System |
| Davol INC. | $15,225.00 | 2021-2023 | |
| Ethicon INC. | $12,276.11 | 2019-2024 | |
| Thd America, INC. | $10,070.21 | 2019-2025 | |
| Conmed Corporation | $9,037.89 | 2019-2024 | Airseal |
| Edwards Lifesciences Corporation | $7,699.01 | 2019 | |
| Medtronic, INC. | $6,414.73 | 2021-2025 | Interstim, Eea |
| Medical Device Business Services, INC. | $5,303.76 | 2021-2022 | |
| Vascular Technology, INC. | $300.00 | 2022 | |
| Tela Bio, INC. | $272.96 | 2023-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $153.57 | 2021 | |
| Guard Medical INC. | $133.31 | 2023 | Npseal Large, Npseal (5), Npseal Medium |
| Rti Surgical, INC | $121.42 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $103.73 | 2019 | |
| Smith+Nephew, INC. | $101.10 | 2023 | Pico 14, Renasys, Renasys Go V2 Home |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $76.34 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $68.76 | 2022 | |
| Integra Lifesciences Corporation | $55.78 | 2022 | |
| Becton, Dickinson and Company | $28.17 | 2022 | |
| Coloplast Corp | $26.71 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Soliman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.